Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C060229 |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
C038237 |
1-oleoyl-2-acetylglycerol |
1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
C046728 |
2,2'-azobis(2-amidinopropane) |
2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein | increases oxidation | 12576517
|
C046728 |
2,2'-azobis(2-amidinopropane) |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] | affects cotreatment|decreases reaction|increases oxidation | 12576517
|
C046728 |
2,2'-azobis(2-amidinopropane) |
Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] | decreases reaction|increases oxidation | 12576517
|
C046728 |
2,2'-azobis(2-amidinopropane) |
Pentetic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] | decreases reaction|increases oxidation | 12576517
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene results in decreased expression of APOA1 mRNA | decreases expression | 16917068
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of APOA1 mRNA | affects expression | 21346803
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]] | affects cotreatment|increases reaction|increases secretion | 20083572
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal binds to APOA1 protein | affects binding | 18778096
|
C041594 |
4-nonylphenol |
4-nonylphenol affects the expression of APOA1 mRNA | affects expression | 15792627
|
C418762 |
9,12-dioxo-10-dodecenoic acid |
9,12-dioxo-10-dodecenoic acid binds to APOA1 protein | affects binding | 18778096
|
C119006 |
9-hydroxy-12-oxo-10(E)-dodecenoic acid |
9-hydroxy-12-oxo-10(E)-dodecenoic acid binds to APOA1 protein | affects binding | 18778096
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of APOA1 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of APOA1 protein | affects expression | 16099942
|
D000171 |
Acrolein |
Acrolein affects the metabolism of APOA1 protein | affects metabolic processing | 16126721 16037261
|
D000171 |
Acrolein |
[Acrolein affects the metabolism of APOA1 protein] which results in decreased secretion of Cholesterol | affects metabolic processing|decreases secretion | 16126721
|
D000171 |
Acrolein |
Acrolein inhibits the reaction [APOA1 protein affects the transport of Cholesterol] | affects transport|decreases reaction | 16037261
|
C038518 |
acrylodan |
acrylodan binds to APOA1 protein | affects binding | 11087425
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of APOA1 protein | affects expression | 20106945
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D016718 |
Arachidonic Acid |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D016718 |
Arachidonic Acid |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D001280 |
Atrazine |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 16532367
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of APOA1 mRNA | increases expression | 20440473
|
C532858 |
biotinylated linoleoylglycerylphosphatidylcholine |
biotinylated linoleoylglycerylphosphatidylcholine binds to APOA1 protein | affects binding | 18778096
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of APOA1 mRNA | decreases expression | 17912697 16835292
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of APOA1 mRNA | increases expression | 18418863
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of APOA1 protein | increases expression | 18418863
|
C053342 |
brevetoxin |
brevetoxin analog results in decreased expression of APOA1 mRNA | decreases expression | 14529743
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] | affects cotreatment|decreases reaction|increases oxidation | 12576517
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] | decreases reaction|increases oxidation | 12576517
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of APOA1 mRNA | increases expression | 15816358
|
D002251 |
Carbon Tetrachloride |
Dinoprostone inhibits the reaction [Carbon Tetrachloride results in increased expression of APOA1 mRNA] | decreases reaction|increases expression | 15816358
|
D002635 |
Chenodeoxycholic Acid |
Chenodeoxycholic Acid results in decreased expression of APOA1 protein | decreases expression | 19445040
|
D002784 |
Cholesterol |
1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
[Acrolein affects the metabolism of APOA1 protein] which results in decreased secretion of Cholesterol | affects metabolic processing|decreases secretion | 16126721
|
D002784 |
Cholesterol |
Acrolein inhibits the reaction [APOA1 protein affects the transport of Cholesterol] | affects transport|decreases reaction | 16037261
|
D002784 |
Cholesterol |
APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol] | affects reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
APOA1 protein promotes the reaction [ABCA1 protein results in increased export of Cholesterol] | increases export|increases reaction | 15983222
|
D002784 |
Cholesterol |
APOA1 protein results in increased secretion of Cholesterol | increases secretion | 20056921 12531903
|
D002784 |
Cholesterol |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
CYP27A1 protein promotes the reaction [APOA1 protein results in increased secretion of Cholesterol] | increases reaction|increases secretion | 12531903
|
D002784 |
Cholesterol |
fingolimod promotes the reaction [APOA1 protein results in increased secretion of Cholesterol] | increases reaction|increases secretion | 20056921
|
D002784 |
Cholesterol |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
mastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]] | affects reaction|decreases reaction|increases export | 16118212
|
D002784 |
Cholesterol |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
PLD2 protein affects the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]] | affects reaction|increases export | 16118212
|
D002784 |
Cholesterol |
PLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]] | affects reaction|decreases reaction|increases export | 16118212
|
D002784 |
Cholesterol |
27-hydroxycholesterol promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D002784 |
Cholesterol |
27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D002784 |
Cholesterol |
[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol | affects cotreatment|increases secretion | 20083572
|
D002784 |
Cholesterol |
Cholesterol results in decreased expression of APOA1 protein | decreases expression | 16115471
|
D002784 |
Cholesterol |
Probucol inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|decreases reaction|increases secretion | 20083572
|
D002784 |
Cholesterol |
Probucol inhibits the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]] | affects cotreatment|decreases reaction|increases reaction|increases secretion | 20083572
|
D002784 |
Cholesterol |
STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D002784 |
Cholesterol |
[TO-901317 co-treated with APOA1 protein] results in increased secretion of Cholesterol | affects cotreatment|increases secretion | 20083572
|
D002784 |
Cholesterol |
TO-901317 promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 19509184
|
D008076 |
Cholesterol, HDL |
Fatty Acids, Unsaturated affects the reaction [APOA1 promoter SNP affects the abundance of Cholesterol, HDL] | affects abundance|affects reaction | 11756058
|
D008076 |
Cholesterol, HDL |
PON1 protein binds to [APOA1 protein binds to Cholesterol, HDL] | affects binding | 16128586
|
C017133 |
chromous chloride |
chromous chloride affects the expression of APOA1 mRNA | affects expression | 12679171
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of APOA1 mRNA | decreases expression | 20106945
|
C017160 |
cypermethrin |
cypermethrin results in increased expression of APOA1 mRNA | increases expression | 9650644
|
D003687 |
Dehydroepiandrosterone |
Dehydroepiandrosterone results in decreased expression of APOA1 mRNA | decreases expression | 18709148
|
D003907 |
Dexamethasone |
Dexamethasone affects the expression of APOA1 mRNA | affects expression | 15102944
|
D003994 |
Bucladesine |
27-hydroxycholesterol promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D003994 |
Bucladesine |
27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D003994 |
Bucladesine |
[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 20083572
|
D003994 |
Bucladesine |
[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol | affects cotreatment|increases secretion | 20083572
|
D003994 |
Bucladesine |
Probucol inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|decreases reaction|increases secretion | 20083572
|
D003994 |
Bucladesine |
Probucol inhibits the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]] | affects cotreatment|decreases reaction|increases reaction|increases secretion | 20083572
|
D003994 |
Bucladesine |
STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 mRNA] | affects cotreatment|increases expression|increases reaction | 20083572
|
D003994 |
Bucladesine |
STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D003994 |
Bucladesine |
TO-901317 promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 19509184
|
D004052 |
Diethylnitrosamine |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOA1 protein | affects cotreatment|increases expression | 20935162
|
C056213 |
dioleoyl ethylene glycol |
dioleoyl ethylene glycol inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D004237 |
Diuron |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 16532367
|
D004365 |
Drugs, Chinese Herbal |
Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 16297877
|
D004365 |
Drugs, Chinese Herbal |
Drugs, Chinese Herbal results in increased expression of APOA1 mRNA | increases expression | 16297877
|
D004365 |
Drugs, Chinese Herbal |
PPARA protein affects the reaction [Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]] | affects reaction|decreases expression|decreases reaction | 16297877
|
D004365 |
Drugs, Chinese Herbal |
PPARA protein affects the reaction [Drugs, Chinese Herbal results in increased expression of APOA1 mRNA] | affects reaction|increases expression | 16297877
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of APOA1 mRNA | decreases expression | 17912697 16835292
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of APOA1 mRNA | decreases expression | 17606305 16872691
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 17942748
|
D005231 |
Fatty Acids, Unsaturated |
Fatty Acids, Unsaturated affects the reaction [APOA1 promoter SNP affects the abundance of Cholesterol, HDL] | affects abundance|affects reaction | 11756058
|
D011345 |
Fenofibrate |
Fenofibrate results in decreased expression of APOA1 protein | decreases expression | 19445040
|
C098720 |
fingolimod |
fingolimod promotes the reaction [APOA1 protein results in increased secretion of Cholesterol] | increases reaction|increases secretion | 20056921
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of APOA1 mRNA | decreases expression | 18035473
|
D005485 |
Flutamide |
Flutamide results in decreased expression of APOA1 mRNA | decreases expression | 16835292
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 19509184
|
D005632 |
Fructose |
Fructose results in increased expression of APOA1 mRNA | increases expression | 9322794
|
D005632 |
Fructose |
Fructose results in increased expression of APOA1 protein | increases expression | 9322794
|
C055328 |
ginsenoside Rf |
ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 16297877
|
C055328 |
ginsenoside Rf |
ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein] | decreases expression|decreases reaction | 16297877
|
C055328 |
ginsenoside Rf |
ginsenoside Rf results in decreased expression of APOA1 protein | decreases expression | 16297877
|
C055328 |
ginsenoside Rf |
PPARA protein affects the reaction [ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]] | affects reaction|decreases expression|decreases reaction | 16297877
|
D036145 |
Ginsenosides |
Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 16297877
|
D036145 |
Ginsenosides |
Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein] | decreases expression|decreases reaction | 16297877
|
D036145 |
Ginsenosides |
Ginsenosides results in decreased expression of APOA1 protein | decreases expression | 16297877
|
D036145 |
Ginsenosides |
Ginsenosides results in increased expression of APOA1 mRNA | increases expression | 16297877
|
D036145 |
Ginsenosides |
PPARA protein affects the reaction [Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]] | affects reaction|decreases expression|decreases reaction | 16297877
|
D036145 |
Ginsenosides |
PPARA protein affects the reaction [Ginsenosides results in increased expression of APOA1 mRNA] | affects reaction|increases expression | 16297877
|
D005947 |
Glucose |
Glucose results in decreased expression of APOA1 mRNA | decreases expression | 9668074
|
D005947 |
Glucose |
Glucose results in increased expression of APOA1 mRNA | increases expression | 9322794
|
D005947 |
Glucose |
Glucose results in increased expression of APOA1 protein | increases expression | 9322794
|
D005990 |
Glycerol |
Glycerol analog promotes the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | increases expression|increases reaction | 19013290
|
D018684 |
Glycine Agents |
Glycine Agents results in increased expression of APOA1 mRNA | increases expression | 16532367
|
C010972 |
glycolaldehyde |
glycolaldehyde inhibits the reaction [ABCA1 protein binds to APOA1 protein] | affects binding|decreases reaction | 15983222
|
D006037 |
Glyoxal |
Glyoxal inhibits the reaction [ABCA1 protein binds to APOA1 protein] | affects binding|decreases reaction | 15983222
|
C412815 |
GW 4064 |
GW 4064 results in decreased expression of APOA1 protein | decreases expression | 19445040
|
C453899 |
GW 7647 |
GW 7647 results in increased expression of APOA1 protein | increases expression | 19445040
|
C051140 |
iron(II)-ascorbic acid complex |
iron(II)-ascorbic acid complex results in decreased expression of APOA1 protein | decreases expression | 10898742
|
C028904 |
isoproturon |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 16532367
|
C060893 |
L 663536 |
L 663536 inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 19883121
|
C060893 |
L 663536 |
L 663536 results in decreased expression of APOA1 protein | decreases expression | 19883121
|
C099406 |
L 742694 |
L 742694 affects the expression of APOA1 mRNA | affects expression | 15102944
|
C037500 |
mastoparan |
mastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]] | affects reaction|decreases reaction|increases export | 16118212
|
C003297 |
nandrolone decanoate |
nandrolone decanoate results in decreased expression of APOA1 protein | decreases expression | 16153628
|
D019829 |
Nevirapine |
Nevirapine results in increased expression of APOA1 protein | increases expression | 19667106
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of APOA1 mRNA | decreases expression | 12102619
|
D019787 |
Linoleic Acid |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D019787 |
Linoleic Acid |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D019787 |
Linoleic Acid |
PLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]] | affects reaction|decreases reaction|increases export | 16118212
|
D019301 |
Oleic Acid |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D019301 |
Oleic Acid |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
C008757 |
palmitoleic acid |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
C008757 |
palmitoleic acid |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D004369 |
Pentetic Acid |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] | affects cotreatment|decreases reaction|increases oxidation | 12576517
|
D004369 |
Pentetic Acid |
Pentetic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA1 protein] | decreases reaction|increases oxidation | 12576517
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of APOA1 mRNA | decreases expression | 17681415
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of APOA1 mRNA | decreases expression | 18709148
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of APOA1 protein | affects expression | 16099942
|
D010634 |
Phenobarbital |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOA1 protein | affects cotreatment|increases expression | 20935162
|
D010672 |
Phenytoin |
Phenytoin results in increased expression of APOA1 mRNA | increases expression | 15136057
|
D010716 |
Phosphatidylinositols |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
dioleoyl ethylene glycol inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
Glycerol analog promotes the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | increases expression|increases reaction | 19013290
|
D010716 |
Phosphatidylinositols |
MAPK1 protein affects the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | affects reaction|increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
MAPK3 protein affects the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | affects reaction|increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
Phosphatidylinositols results in decreased degradation of APOA1 protein | decreases degradation | 19013290
|
D010716 |
Phosphatidylinositols |
Phosphatidylinositols results in increased expression of APOA1 protein | increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
sulindac sulfide inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
tricyclodecane-9-yl-xanthogenate inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D010716 |
Phosphatidylinositols |
U 0126 inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D010743 |
Phospholipids |
APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids] | affects reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
C006253 |
pirinixic acid |
[pirinixic acid co-treated with SB 203580] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA] | affects cotreatment|decreases expression|decreases reaction | 19883121
|
C006253 |
pirinixic acid |
[pirinixic acid co-treated with U 0126] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA] | affects cotreatment|decreases expression|decreases reaction | 19883121
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of APOA1 protein | decreases expression | 19883121
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of APOA1 mRNA | increases expression | 19883121
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of APOA1 protein | increases expression | 19445040
|
C006253 |
pirinixic acid |
Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein] | decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 protein] | decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of APOA1 mRNA | decreases expression | 16297877
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of APOA1 protein | decreases expression | 16297877
|
C006253 |
pirinixic acid |
PPARA protein affects the reaction [Drugs, Chinese Herbal inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]] | affects reaction|decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
PPARA protein affects the reaction [ginsenoside Rf inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]] | affects reaction|decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
PPARA protein affects the reaction [Ginsenosides inhibits the reaction [pirinixic acid results in decreased expression of APOA1 mRNA]] | affects reaction|decreases expression|decreases reaction | 16297877
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of APOA1 protein | affects expression | 16099942
|
D011341 |
Probucol |
Probucol inhibits the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|decreases reaction|increases secretion | 20083572
|
D011341 |
Probucol |
Probucol inhibits the reaction [STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol]] | affects cotreatment|decreases reaction|increases reaction|increases secretion | 20083572
|
D015232 |
Dinoprostone |
Dinoprostone inhibits the reaction [Carbon Tetrachloride results in increased expression of APOA1 mRNA] | decreases reaction|increases expression | 15816358
|
C009159 |
rapeseed oil |
rapeseed oil affects the expression of APOA1 mRNA | affects expression | 16177195
|
C093642 |
SB 203580 |
[pirinixic acid co-treated with SB 203580] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA] | affects cotreatment|decreases expression|decreases reaction | 19883121
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of APOA1 mRNA | decreases expression | 17450228
|
C025462 |
sulindac sulfide |
sulindac sulfide inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of APOA1 mRNA | increases expression | 16835292
|
D013656 |
Taurocholic Acid |
Taurocholic Acid results in decreased expression of APOA1 protein | decreases expression | 19445040
|
C003377 |
taxifolin |
taxifolin results in increased expression of APOA1 protein | increases expression | 11108730
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APOA1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of APOA1 mRNA | decreases expression | 15800033
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of APOA1 mRNA | decreases expression | 15703262
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APOA1 mRNA | increases expression | 16267337
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APOA1 mRNA | increases expression | 16497791 15644576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APOA1 protein | increases expression | 16497791
|
C423915 |
TO-901317 |
TO-901317 inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA] | decreases expression|decreases reaction | 19883121
|
C423915 |
TO-901317 |
TO-901317 results in decreased expression of APOA1 protein | decreases expression | 19883121
|
C423915 |
TO-901317 |
[TO-901317 co-treated with APOA1 protein] results in increased secretion of Cholesterol | affects cotreatment|increases secretion | 20083572
|
C423915 |
TO-901317 |
TO-901317 promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased secretion of Cholesterol] | affects cotreatment|increases reaction|increases secretion | 20083572
|
C066340 |
tolcapone |
tolcapone binds to APOA1 protein | affects binding | 19783845
|
C046498 |
tricyclodecane-9-yl-xanthogenate |
tricyclodecane-9-yl-xanthogenate inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
C113580 |
U 0126 |
[pirinixic acid co-treated with U 0126] inhibits the reaction [TNF protein results in decreased expression of APOA1 mRNA] | affects cotreatment|decreases expression|decreases reaction | 19883121
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein] | decreases reaction|increases expression | 19013290
|
D015032 |
Zinc |
Zinc results in decreased expression of APOA1 protein | decreases expression | 12679171
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.73 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
9.77 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
9.77 | 3425630 10563481 9677735 8986270 6195326 9118846 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.77 | 14514962 11752688 15322242 |
MESH:D000038 |
Abscess |
|
Drugs, Chinese Herbal |
5.50 | 15043669 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.13 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
4.70 | 17694057 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.60 | 17202136 17190629 16889938 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
6.83 | 21297076 20525806 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
6.83 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
marker/mechanism |
|
| 15378696 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
3.24 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.24 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
4.88 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
4.88 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
18.36 | 17162532 19052882 18056438 16434500 17620307 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.36 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.36 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.36 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
4.32 | 17942926 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.88 | 15276417 |
MESH:D000309 |
Adrenal Insufficiency |
|
Dehydroepiandrosterone |
4.98 | 17302879 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.09 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
6.73 | 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
cypermethrin |
6.73 | 16487989 |
MESH:D017109 |
Akathisia, Drug-Induced |
|
tolcapone |
5.48 | 11080934 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
12.34 | 14523054 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
12.34 | 17570602 14715435 15207723 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
12.34 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
12.34 | 18759972 |
MESH:D000544 |
Alzheimer Disease |
|
tolcapone |
12.34 | 20150427 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
12.34 | 16580781 17119284 16325427 16410023 |
MESH:C538249 |
Amyloidosis, familial visceral |
marker/mechanism |
|
| |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.55 | 10965797 |
MESH:D000740 |
Anemia |
|
Drugs, Chinese Herbal |
6.69 | 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
6.69 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.14 | 16916123 |
MESH:D000787 |
Angina Pectoris |
|
Drugs, Chinese Herbal |
4.61 | 11477813 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.03 | 10982225 |
MESH:D000860 |
Anoxia |
|
Oleic Acid |
5.10 | 15090967 |
MESH:D001004 |
Anus Diseases |
|
Drugs, Chinese Herbal |
5.15 | 15043669 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
4.84 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
9.39 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
9.39 | 10388637 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
18.10 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
18.10 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
18.10 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
18.10 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
5.54 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
5.54 | 15885639 |
MESH:D015210 |
Arthritis, Gouty |
|
Drugs, Chinese Herbal |
4.95 | 19655406 |
MESH:D001249 |
Asthma |
|
Zinc |
2.66 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
15.01 | 11166758 9059518 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
15.01 | 17363696 16126721 16037261 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
15.01 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
fingolimod |
15.01 | 20056921 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
15.01 | 15136057 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.27 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
2.27 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Linoleic Acid |
2.27 | 18582451 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
4.96 | 15976003 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
6.37 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
6.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.98 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.20 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
7.43 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
Drugs, Chinese Herbal |
7.43 | 9881647 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
3.91 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.36 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.36 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.36 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.36 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.36 | 20544844 20005174 15668708 18425577 15565566 17242785 19155303 19059307 18629630 18855134 20135344 19142967 18351453 19103187 19115204 18984771 11161223 16273361 17049068 19289846 16873071 16202921 21138602 19288272 19189210 20065188 18821012 19244106 19084267 17261762 20859285 20390343 19221464 19410462 21152245 16818667 17893378 19011961 19066611 19200415 19487384 17440819 18815881 18997820 19189212 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.00 | 15721981 16097048 16227642 16124888 10355542 18705752 15673190 16011737 16050911 16192424 3786805 15700767 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.15 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.72 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
18.33 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
18.33 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
18.33 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
18.33 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
18.33 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
18.33 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
18.33 | 16830150 19519916 16935385 19394651 16569478 19701751 18788625 20524982 20214788 18210153 19539802 16807293 10672840 20935162 19919837 17428255 18978308 18393292 20727157 19052882 16502159 20084675 17173139 17761372 17138121 18785209 16328049 3084413 20514400 18506893 16698587 21159647 17978847 18971187 16540662 20512989 19171122 19418558 16288022 10737359 19208518 18665156 16878318 19822196 17055752 20007298 3581430 19335982 19107877 19383236 20101231 17162532 16681979 18691550 16779866 11831363 18056438 20432363 18494052 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
18.33 | 17173139 1701930 6705139 20007298 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
18.33 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
18.33 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.19 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.11 | 12391285 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
5.71 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
5.71 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
5.71 | 16543248 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
2.91 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
1.87 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.08 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.06 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.85 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.85 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
14.85 | 17174075 7505956 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
14.85 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.85 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
9.08 | 4080065 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
9.08 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.03 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.03 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
9.71 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
9.71 | 17681005 15861022 17333356 16105132 17110522 11677210 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
9.71 | 19176532 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.07 | 11748493 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
3.67 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
4.77 | 10789828 2227380 1687470 6856622 3877104 6862529 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.77 | 12621046 15668235 15340226 16354765 8697196 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
4.42 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.33 | 15824018 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
2.93 | 17597105 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
7.09 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.09 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
3.91 | 18504504 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
4.33 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
4.33 | 8986270 19952982 9212184 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.33 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
4.33 | 19302082 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.30 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.30 | 18551238 |
MESH:D003556 |
Cystitis |
|
Acrolein |
4.58 | 12161096 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.58 | 19031437 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
4.88 | 19427377 |
MESH:D003866 |
Depressive Disorder |
|
tolcapone |
3.70 | 7768276 11224284 |
MESH:D003865 |
Depressive Disorder, Major |
|
tolcapone |
4.21 | 10440460 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.69 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
1.99 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.52 | 16479319 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
3.83 | 18603373 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Dehydroepiandrosterone |
3.38 | 16616286 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
5.56 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
5.56 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
5.56 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
2.79 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
6.07 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
6.07 | 11488427 7237001 10446763 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
4.61 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
4.72 | 15024534 |
MESH:D056486 |
Drug-Induced Liver Injury |
marker/mechanism |
|
| 16099942 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
19.30 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
19.30 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
19.30 | 18713872 16109766 10663392 12705907 11739529 19085960 11743745 18071297 12540782 11461765 15619225 16177239 14550746 16081117 10915739 19416960 12153990 16227642 12594235 11834606 11287661 12958197 19739265 16781746 19420014 14725611 19164858 14986274 11529661 11421492 17906064 2444490 19923254 15968718 12392966 10774834 17562736 19370779 16485898 16393943 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
19.30 | 15998439 10092053 4309450 6884620 3732212 2869522 3786805 21278145 11566570 10915739 6623471 7440962 17522070 19085960 19336974 15968718 15027814 16177239 7120509 9327722 16227642 7179309 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
19.30 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Drugs, Chinese Herbal |
19.30 | 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Nevirapine |
19.30 | 14986274 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
19.30 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
tolcapone |
19.30 | 16604736 19783845 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.28 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.14 | 11462148 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
tolcapone |
4.59 | 11455177 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
6.90 | 18367378 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
6.90 | 16707586 |
MESH:D004417 |
Dyspnea |
|
cypermethrin |
4.58 | 16487989 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.26 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.70 | 12438553 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
17.86 | 9831321 15177302 16716910 11698051 7990266 9599246 |
MESH:D004487 |
Edema |
|
Dexamethasone |
17.86 | 19703484 |
MESH:D004487 |
Edema |
|
L 663536 |
17.86 | 7990266 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
17.86 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
17.86 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
17.86 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.09 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
15.83 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
15.83 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
15.83 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
15.83 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
5.89 | 16569247 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
5.89 | 19155303 20544844 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.32 | 10568697 9294722 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
4.43 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.42 | 6251365 1399206 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.33 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
7.66 | 11558140 3922381 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
7.66 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
5.42 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
5.42 | 821787 11434505 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.86 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
9.08 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
9.08 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
8.21 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
8.21 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.30 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
3.68 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
3.68 | 16543248 |
MESH:D054908 |
Extensively Drug-Resistant Tuberculosis |
|
tolcapone |
5.13 | 19578428 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.38 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
30.75 | 12631006 16239168 19224547 17595544 61145 12795759 16045604 15959796 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
30.75 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
30.75 | 18296743 19004024 19551842 17967931 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
30.75 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
30.75 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
30.75 | 19196556 18395287 18641190 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
30.75 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
30.75 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.69 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
8.15 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
8.15 | 11858732 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
7.52 | 11852909 |
MESH:D005334 |
Fever |
|
Dinoprostone |
7.52 | 16997862 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.73 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.38 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
19.58 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
19.58 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
19.58 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
19.58 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.58 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
8.47 | 16983495 |
MESH:D005756 |
Gastritis |
|
Zinc |
8.47 | 17241300 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
3.88 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
10.26 | 8708960 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
10.26 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.42 | 16390469 14659971 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
4.58 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.78 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.40 | 17217573 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
4.38 | 11284996 11554966 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
4.81 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
4.81 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.32 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Zinc |
5.32 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
4.95 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
3.79 | 17241300 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.62 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
11.64 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
cypermethrin |
11.64 | 16487989 |
MESH:D006505 |
Hepatitis |
|
Drugs, Chinese Herbal |
11.64 | 18339527 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
3.91 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
14.36 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
14.36 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.36 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.36 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.72 | 7520565 |
MESH:D015658 |
HIV Infections |
|
Nevirapine |
4.41 | 11141242 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.50 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.23 | 8697196 18606429 16959395 16354765 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
9.48 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
9.48 | 16793879 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
9.48 | 12083418 |
MESH:D017588 |
Hyperandrogenism |
|
Flutamide |
4.65 | 15356085 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.73 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
16.09 | 17873880 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
16.09 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
16.09 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
16.09 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.48 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
3.98 | 10459572 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.22 | 18563319 15752949 19008412 14757778 18360027 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
7.10 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
7.10 | 15752949 |
MESH:D006951 |
Hyperlipoproteinemias |
|
Fatty Acids, Unsaturated |
5.46 | 18435438 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
3.81 | 17604070 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
9.18 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
9.18 | 17042910 |
MESH:D006973 |
Hypertension |
|
Fructose |
9.18 | 14568997 16843071 14633139 14573337 19008412 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.18 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.31 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
L 663536 |
4.57 | 14726295 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.37 | 19342510 19799862 |
MESH:D052456 |
Hypoalphalipoproteinemias |
marker/mechanism |
|
| |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.03 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.72 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
7.94 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.94 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.94 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
20.06 | 15177302 9831321 17371808 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
20.06 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
20.06 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
20.06 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
20.06 | 17296493 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
20.06 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
20.06 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
20.06 | 12878042 12200463 |
MESH:D007299 |
Insect Bites and Stings |
|
cypermethrin |
5.16 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.99 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.99 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
12.99 | 19799862 19586609 14757778 18981581 19008412 18563319 19342510 14633139 17133782 14573337 18057795 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.99 | 16306350 |
MESH:D007511 |
Ischemia |
|
Zinc |
3.85 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.61 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.63 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.53 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
13.53 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.53 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.53 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
13.53 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
3.70 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.28 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.28 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.28 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.28 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
4.32 | 17134702 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Drugs, Chinese Herbal |
3.52 | 15802533 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
9.49 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
9.49 | 16972261 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.43 | 8812269 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.55 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
15.35 | 16943688 17157831 16221502 21278145 11408273 11903743 17334410 17174718 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
15.35 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
15.35 | 18665156 20032147 19638242 18522880 18407596 |
MESH:D008103 |
Liver Cirrhosis |
|
Drugs, Chinese Herbal |
15.35 | 17163593 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
15.35 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.31 | 18251166 14724832 17761835 15959796 15818738 18166357 18472094 17944888 12649538 18156304 17869086 18481824 17631135 18429990 16638106 16027843 15996030 18420326 15123356 15876570 15730626 17640975 16136751 12445421 12546737 12609069 18210741 18395095 12741479 12667390 12632512 17525996 12898905 18418968 18376398 16033810 18395914 11481614 15673190 15057751 16192424 18705752 17766677 17976157 15362042 16097048 17805973 20821823 17714472 16011737 15338365 17900296 17481882 13678700 12586293 18205269 18187930 18279442 18277467 14716833 18339082 17721639 18472332 10355542 12958196 12666154 16248980 18263696 12632514 18054572 17557913 15650968 14748882 17565644 17708605 15925388 18412020 18006644 17698563 14716496 15893842 14620537 17922224 15931870 15370692 18317297 14512876 16015684 12445418 16116963 17823541 15052691 12389079 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
10.31 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
10.31 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Drugs, Chinese Herbal |
10.31 | 15641146 15744066 15339415 15754396 18371158 17881167 17666798 12632512 17036385 18606216 15818738 16610055 18237412 18567088 17629604 15849816 15383259 15763062 15864749 17348192 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
10.31 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.31 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
10.31 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.31 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
17.74 | 19460945 16611625 19014921 16610002 12969438 19784758 11587558 12587719 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
17.74 | 15830285 16246199 16964402 17285989 15720792 |
MESH:D008107 |
Liver Diseases |
|
cypermethrin |
17.74 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
17.74 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
17.74 | 15816358 |
MESH:D008107 |
Liver Diseases |
|
Drugs, Chinese Herbal |
17.74 | 17207593 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
17.74 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
17.74 | 14986274 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.38 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.06 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
7.06 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
44.28 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
44.28 | 15890375 18177683 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
44.28 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
44.28 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
44.28 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Dehydroepiandrosterone |
44.28 | 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
44.28 | 10737359 18977376 20492335 12112319 20405173 21071580 19812893 19294768 19638242 20101389 19499222 20583210 20452335 19996281 19256749 21167192 18754104 21278145 9163691 19642983 18644402 19690152 21047994 19255062 19090486 19426721 2422723 19254457 19551842 12771043 19850985 18648771 20434301 15175105 16942905 2862719 18978307 20137499 20118626 19427195 20501860 19833225 19073162 15885732 |
MESH:D008113 |
Liver Neoplasms |
|
Drugs, Chinese Herbal |
44.28 | 18339527 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
44.28 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
44.28 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
44.28 | 19073162 19482888 8742319 15975961 21047994 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
44.28 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
44.28 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
44.28 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
44.28 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
27.47 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
27.47 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
27.47 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dehydroepiandrosterone |
27.47 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
27.47 | 3124819 18079962 2563599 18775883 19126423 18164116 17854601 18253720 21159647 18544905 17174075 17942915 19004024 18282651 18093689 9362446 16842330 18308698 19519916 19539802 16267830 19009564 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
27.47 | 18253720 18775883 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
27.47 | 1399818 6150874 18308698 17172636 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Probucol |
27.47 | 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
27.47 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
5.88 | 11504702 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
5.88 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Oleic Acid |
4.58 | 15090967 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| 19180532 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
14.23 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.23 | 18816296 17053015 18569708 20135361 20464547 6695378 18520028 20869020 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
14.23 | 11696405 11246140 19359593 18597497 19925653 16337739 15390079 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
14.23 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
14.23 | 20970405 21163286 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Drugs, Chinese Herbal |
14.23 | 18339527 |
MESH:D008175 |
Lung Neoplasms |
|
L 663536 |
14.23 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
14.23 | 15276417 19931552 17077188 16712894 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
14.23 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.23 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
2.97 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
12.92 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Dehydroepiandrosterone |
12.92 | 16457693 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Drugs, Chinese Herbal |
12.92 | 14758024 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
12.92 | 16827153 11731420 19196723 19196722 14580682 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
12.92 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
3.73 | 19453300 |
MESH:D008545 |
Melanoma |
|
Glucose |
4.02 | 14993021 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.02 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.02 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.38 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
8.39 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
8.39 | 10803710 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
3.33 | 9212184 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.14 | 1916698 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.14 | 19165636 17098227 17261469 18497449 16815490 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
3.97 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.00 | 3537620 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
8.68 | 11304026 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
8.68 | 14659530 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.55 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
2.91 | 16118317 15744524 15867202 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.73 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.02 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
4.64 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
4.64 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.36 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.31 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
9.84 | 17484760 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
9.84 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
4.61 | 1896199 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
7.70 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
7.70 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
4.39 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
4.39 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.18 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
8.04 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.04 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.04 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.04 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
2.90 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Nevirapine |
8.74 | 19152342 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
8.74 | 19196722 19189210 19200415 |
MESH:D009393 |
Nephritis |
|
Acrolein |
5.47 | 12653641 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.63 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.60 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
7.06 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
7.06 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
5.80 | 9118846 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
5.80 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
10.27 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
10.27 | 11342003 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
10.27 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.30 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
9.75 | 20557099 9802331 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
9.75 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
5.84 | 19632207 20518802 21332399 17217161 16723640 18457598 11836018 18674790 20132043 |
MESH:D009765 |
Obesity |
|
Fructose |
5.84 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
5.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
6.54 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
6.54 | 16049721 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
5.66 | 18500342 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
9.42 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
9.42 | 17016548 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Dehydroepiandrosterone |
8.30 | 16397352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Drugs, Chinese Herbal |
8.30 | 16548355 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.19 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.17 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
4.17 | 16211241 |
MESH:D010146 |
Pain |
|
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione |
7.78 | 18987195 |
MESH:D010146 |
Pain |
|
Acetaminophen |
7.78 | 16870215 |
MESH:D010146 |
Pain |
|
Phenytoin |
7.78 | 15215642 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
6.68 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
L 663536 |
6.68 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
6.68 | 16965848 |
MESH:D010195 |
Pancreatitis |
|
Taurocholic Acid |
4.49 | 20035747 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.94 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
9.36 | 17690948 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
9.36 | 17218051 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
9.36 | 19014385 |
MESH:D010300 |
Parkinson Disease |
|
tolcapone |
9.36 | 18328768 9305320 20334432 9591521 8635184 16758261 1977408 20216409 19578428 8739811 11746615 10651109 11432539 19783845 11586115 17089403 11793426 9333106 9708959 7566641 9754991 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.43 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
10.76 | 11550810 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
10.76 | 11550810 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
4.37 | 11893704 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Flutamide |
4.28 | 15356085 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.35 | 9212184 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.80 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
11.28 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
11.28 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
11.28 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.04 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.53 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
11.74 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
11.74 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.74 | 11399792 11118676 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.48 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.94 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.94 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flutamide |
1.94 | 3169114 |
MESH:D011471 |
Prostatic Neoplasms |
|
Nevirapine |
1.94 | 19152342 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.94 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.94 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
1.94 | 16700911 16517595 12429649 16606632 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
7.46 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
L 663536 |
7.46 | 17827870 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
9.86 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
9.86 | 12752131 8603615 1419762 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.88 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
3.99 | 10548101 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
5.58 | 15466366 |
MESH:D011654 |
Pulmonary Edema |
|
Oleic Acid |
4.99 | 15090967 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Drugs, Chinese Herbal |
3.35 | 16987627 |
MESH:D012003 |
Rectal Fistula |
|
Drugs, Chinese Herbal |
5.15 | 15043669 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
4.23 | 12732208 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
1.93 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.34 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oleic Acid |
7.34 | 18549715 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
3.74 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.50 | 16584753 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Drugs, Chinese Herbal |
4.46 | 15015336 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.33 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.33 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
9.33 | 11442880 16876388 3137016 4039156 |
MESH:D012640 |
Seizures |
|
Phenytoin |
9.33 | 16876388 3691417 10029267 15946322 9844417 11044598 19919933 3137016 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.02 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.84 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
9.84 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.84 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.84 | 16192470 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
5.23 | 11254748 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
5.57 | 19812052 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
8.86 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
8.86 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.24 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.15 | 12854658 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
4.37 | 20235791 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.53 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 15378696 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.83 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.83 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Drugs, Chinese Herbal |
2.83 | 18339527 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
2.81 | 15138204 |
MESH:D020521 |
Stroke |
|
Acrolein |
3.90 | 16269634 |
MESH:D013345 |
Subarachnoid Hemorrhage |
|
Drugs, Chinese Herbal |
4.95 | 17634840 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.19 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.88 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.47 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.09 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
5.08 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
5.08 | 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
3.69 | 16543248 |
MESH:D014376 |
Tuberculosis |
|
Chenodeoxycholic Acid |
4.48 | 16040207 |
MESH:D018088 |
Tuberculosis, Multidrug-Resistant |
|
tolcapone |
5.13 | 19578428 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.53 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.53 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.53 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.53 | 17306315 11723127 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.53 | 8653321 16712894 17572228 |
MESH:D014570 |
Urologic Diseases |
|
cypermethrin |
5.05 | 16487989 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.34 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.34 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.25 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.06 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.19 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
7.17 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
7.17 | 18645019 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
9.07 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
9.07 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.63 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.78 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.81 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
tolcapone |
4.43 | 10573327 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.43 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.05 | 16723640 |
MESH:D014947 |
Wounds and Injuries |
|
Drugs, Chinese Herbal |
3.87 | 16313111 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.63 | 17120751 |